Houston-based Sportlo is shooting for a one-stop-shop platform for sporting programs in Houston. Cade Martin/Getty Images

In virtually no time at all, Sportlo has built its reputation on the simplest of foundations: community.

Thilo Borgmann and Sebastian Henke founded the local hub for sports parents earlier this year as a tool for sports moms and dads to stay connected with local leagues, sports clubs, coaches, and other parents with children involved in youth sports in the greater Houston area.

"We make it easy for sports parents to keep up with what's happening in their local youth sports community," says Henke. "With our platform, they can discover tryouts, camps, and sports clubs. They can also join and create groups, find private coaches for their kids, and more."

Borgmann and Henke are both former NCAA Division 1 soccer players who starred while they were student athletes at Houston Baptist University, then went on to become well-known private coaches.

The sports-loving duo saw a dearth of useful information for sports parents on popular social media sites, so they created the platform to give users a central place to communicate with each other, join and create groups, discover tryouts and camps for their children and find private coaches across the city to help their young athletes reach their goals.

"We were both involved in sports for most of our lives and then got into private coaching," says Henke. "Overall, what we saw was that there is an entire ecosystem of youth sports and it was very much unorganized."

Henke says sports clubs weren't able to reach potential members and their parents. He says they envisioned a one-stop-shop approach to the sports ecosystem.

"So, Sportlo is focused on sports parents, but within the community, we try to connect persons with coaches, with clubs, with colleges and so on," Henke says. "That's the vision behind it, so people will have a place to have a community, to get advice and tips and then they will have access to certain services and information."

The plan for Sportlo has already evolved in its short life. Originally the platform was going to support just private coaching.

"After we got more feedback from parents and first users, we started to adapt the product and rebuilt the product," Henke says. "Based on the surveys we collected online, parents wanted us to find ways how to connect them with each other, so that's why we started building it as a new page and that's how we realized where it needed to go."

The biggest lesson in listening to their users was understanding that any initial vision to help a community must also be focused on or include what's intrinsically valuable to the users.

"Too often, people get focused on their own ideas and forget that feedback offers surprising moments," says Henke. "Users gave us a whole new path, which kept us from going in the direction where users wouldn't want the product to go."

Feedback from users is key, Henke says, and he recommends startup founders prioritize user experience and constructive criticism.

"All of the ideas that we had in our head, at some point we had to stop and reevaluate them and then focus on the most important thing first and then go from there," he says.

Still, the launch of Sportlo was not without its own unique challenges. Its March go-live date coincided in point of time with the spread of COVID-19, which ultimately turned into a worldwide pandemic.

"We haven't had to make any major changes," says Henke. "But groups on the platform have focused on that topic because there are no sports happening at the moment and they are eager to get them back. But other than that, it's not something we've had to focus on. But for parents, they've focused on related topics, like how to keep their kids busy at home doing exercises, things like that, or when discussing when their kids' clubs are starting back up and how to keep kids safe."

In addition to forming groups and sharing a variety of sports-related topics, parents can post pictures and videos of their child's latest tournament or game, get access to useful articles shared by fellow parents and find recommended sports products for themselves or their child.

"The main reason we added that social component was because we wanted to have a user timeline so when they log in, all the users can see something sports related," says Borgmann. "There's so much noise, with politics and posts that are only about the coronavirus and all that, so we wanted to focus on sports and have parents be able to show how their kid is doing, see other kids in action and support each other with a focus on sports without seeing all the other distractions that might be on other platforms."

For now, Sportlo is focused solely on keeping Houston informed, but it will look to expand to other cities and states when the time comes.

"We are focused right now only on Houston, because we know Houston and Texas and we've experienced different levels of sports in this area, so we want to stay local," says Henke. "Then, the next step is we intend to take it to other cities within Texas. And at some point, our vision is to have the entire youth ecosystem of the United States."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.